4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Neoplasms, Second Primary: new trials by email Literature Review of Neoplasms, Second Primary trials Research Report on Neoplasms, Second Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment Varenicline, Bupropion, Long-acting nicotine replacement therapy - Smoking Cessation, Cancer, Treatment-Related | Phase 2 | Completed | Joseph Valentino, MD | 126 | 2021-01-12 | 2026-02-02 |
| FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC 5-FU, Folinic Acid, Irinotecan - Treatment Related Cancer | Phase 2 | Completed | Ludwig-Maximilians - University of Munich | 57 | 2019-09-27 | 2025-04-16 |
| Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia Ex Vivo-activated Autologous Lymph Node Lymphocytes, Laboratory Biomarker Analysis - Anemia, Cancer Fatigue | Phase 2 | Completed | M.D. Anderson Cancer Center | 8 | 2015-12-18 | 2019-10-29 |
| DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer Radiotherapy - Head and Neck Neoplasms, Recurrence | Phase 2 | Completed | University of Aarhus | 100 | 2006-11-01 | 2013-06-19 |
Anemia (1) · Behavior, Addictive (1) · Communicable Diseases (1) · Fever (1) · Head and Neck Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Prolymphocytic (1) · Lymphadenopathy (1) · Lymphocytosis (1) · Recurrence (1) · Smoking Cessation (1) · Thrombocytopenia (1) · Weight Loss (1)
Neoplasms (4) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Blood Platelet Disorders (1) · Body Temperature Changes (1) · Body Weight (1) · Body Weight Changes (1) · Chronic Disease (1) · Compulsive Behavior (1) · Cytopenia (1) · Health Behavior (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Bupropion (1) · Cetuximab (1) · Fluorouracil (1) · Irinotecan (1) · Leucovorin (1) · Nicotine Chewing Gum (1) · Radiotherapy (1) · Tobacco Use Cessation Devices (1) · Varenicline (1) · avelumab (1)
Joseph Valentino, MD (1) · Ludwig-Maximilians - University of Munich (1) · M.D. Anderson Cancer Center (1) · University of Aarhus (1)
United States (2) · Denmark (1) · Germany (1)
Chitra Hosing (1) · Dominik Modest, PD Dr. (1) · Joseph Valentino, MD (1) · Kenneth Jensen, MD (1)
P30CA016672 (1)